The HCPLive Infectious Disease condition center page is a comprehensive resource for clinical news and insights on respiratory health. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for asthma, COPD, interstitial lung disease, COVID-19, and more.
December 9th 2024
In this month's episode of Lungcast, Jacob Sands, MD, discusses the American Lung Association’s recently newly-released 2024 State of Lung Cancer report.
Why Family Caregivers Are Desperate for a Doctor's Advice
Patients discharged from the hospital often rely on a family member to perform complex nursing tasks at home. These caregivers are critical, but too often physicians do not acknowledge these family members' role or help them with care instructions, says Carol Levine of the United Hospital Fund.
Flu Season and Flu Vaccine: NFID Conference Reveals What You Need to Know
September 17th 2015The benefits and risks of vaccinations have been in the forefront of the news lately, especially with children going back to school and presidential debates heating up. Although the Centers for Disease Control and Prevention (CDC) continuously advise that all eligible candidates receive a vaccine, some remain skeptical. The National Foundation for Infectious Diseases (NFID) hosted their annual news conference to discuss the 2014-2015 flu vaccine outcomes and what you need to know as we approach the next season.
Many States Now Require Schools to Stock Epinephrine Autoinjectors
Over the past year, school officials in several of the nation's largest states have implemented new policies to address the growing prevalence and severity of pediatric allergies by increasing access to epinephrine auto-injectors.
Panel Sets New Criteria for Peripherally Inserted Central Catheters
The use of peripherally inserted central catheters (PICCs) has been rising steadily. But they can cause complications. In an article in Annals of Internal Medicine a multispecialty panel reports on the Michigan Appropriateness Guide for Intravenous Catheters (MAGIC). The panel came up with new PICC criteria.
Pulmonology Crisis: Wildfires Have the West Wheezing
Firefighters aren't the only heroes coping with wildfires in the Western US. The record-setting blazes are sending droves of patients with breathing problems to hospitals and clinics seeking help from pulmonologists.
Institute Finds Heart Device Far Too Costly
The cost critics at the non-profit Institute for Clincial and Economic Review today charged that a heart monitoring device is too expensive by 60% and a new cardiac drug costs 17% more than it should. It's the same group that attacked the cost of PCSK9 inhibitors and predicted hepatitis C antivirals would be pricey.
Omalizumab Highly Effective for Treatment of Chronic Spontaneous Urticaria
A study in Drug Design, Development, and Therapy provides further evidence that omalizumab is safe and effective for treatment of chronic spontaneous urticaria (CSU). Omalizumab is currently used to treat adult and pediatric patients with asthma and is FDA-approved for use in patients with CSU refractory to antihistamines. These results further outline the effectiveness of the drug in treating CSU and suggest a bump for omalizumab in the typical treatment protocol for CSU.
Asthma Ally App Can Help Patients Achieve Better Asthma Control
The Asthma Ally app can track patients' symptoms and alert their physicians when those symptoms are not under control, according to findings of a study published in the Annals of Allergy, Asthma and Immunology.
Adding Drug Combination Sees Benefits in COPD Patients
Certain groups of patients with chronic obstructive pulmonary disease (COPD) may see more benefits from adding a combination of aclidinium bromide and formoterol to their existing treatment, according to research conducted by the German Institute for Quality and Efficiency in Health Care (IQWiG).
Tools That Assess Sarcoidosis Severity Should See More Use Across Specialties
A study in JAMA Dermatology provides evidence that the use of two tests to assess cutaneous sarcoidosis disease severity should be expanded. The research has applications for dermatologists, rheumatologists, and pulmonologists, all of whom have a role in treating sarcoidosis.
Binge-Watching Television Spikes Blood Clot Risk
Couch potatoes, beware. According to a recent study presented at the European Society of Cardiology 2015 Congress (ESC) in London, UK, watching television for longer than five hours each day doubles the likelihood of suffering a fatal pulmonary embolism.
Are You Getting Enough Sleep to Fend Off the Common Cold?
September 2nd 2015Cold season is officially here and for the next several months many people will be loading up on vitamin C in hopes of keeping the common, but physically draining, illness at bay. However, gorging on oranges is not necessarily the answer to making it through without the sniffles – but extra sleep might be.
PCSK9 Inhibitor Dramatically Reduces Cholesterol in Patients with Familial Hypercholesterolemia
The Sanofi/Regeneron PCSK9 inhibitor alirocumab (Praluent)- approved in July in the US - lowered cholesterol in patients with familial hypercholesterolemia to levels "unreachable with statins" researchers said at the European Society of Cardiology meeting in London, UK.